We want to thank Global Advances in Health and Medicine for their incredible work. We feel so fortunate to be given an opportunity to share the reason behind GrowBaby with a global platform. Thank you to Dr. Leslie and Dr. Michael Stone, Emily Rydbom, Elliot Stone, Lucas Stone, Lindsey Wilkens, and Kathryn Reynolds for working so tirelessly to make this a reality. Stone Medical, PC, and GrowBaby Health could not have done this without you!
A retrospective chart review analyzed the effect of customized nutri- tion on the incidence of pregnancy-induced hypertension (PIH), gestational diabetes (GDM), and small-and large-for-gestational-age (SGA, LGA) neonates, examining consecutive deliveries between January 1, 2011, and December 31, 2012, at a low-risk community hospital. The population was divided into 3 groups: (1) study group (SG), (2) pri- vate practice (PP), and (3) community healthcare clinic (CHCC). All groups received standard perinatal management, but additionally the study group was analyzed for serum zinc, carnitine, total 25-hydroxy cholecalciferol (25 OH-D), methylene tetrahydrofolate reductase, and catechol-O-methyl transferase poly- morphisms in the first trimester prior to intervention, with subsequent second trimester and postpartum assessment of zinc, carnitine, and 25 OH-D after intervention. Intervention consisted of trimester-by-trimester nutrition and lifestyle education, supplementation of L-methylfolate, magnesium, essential fatty acids, and probiotics for all SG patients, with targeted supplementation of zinc, carnitine, and 25 OH-D. Because of small case occurrence rates of individual conditions in the study group, unreportable reductions were found, except GDM (SG vs CHCC, P value .046 with 95.38% confidence interval [CI]), and PIH (SG vs PP, P value .0505 with 94.95% CIl). The aggregated occurrence rate of the four conditions, however, was significantly lower in the study population than in either comparison population (PP P value .0154 with 98.46% CI, and CHCC P value .0265 with 97.35% CI). Customized nutritional intervention appears to have significantly reduced adverse perinatal outcomes Prospective study within larger, at-risk populations is needed to determine whether customized nutrition improves conditions individually.
For the full article featured in the November publication, please visit http://www.gahmj.com/toc/gahmj/current.
Have a happy and healthy day!
Posted on Nov 21, 2014